BI-RG-587
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BI-RG-587, covering 2008-07-30 to 2011-03-01. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3 [Phase 2]